SEOM clinical guidelines for the treatment of head and neck cancer (2017)
Por:
Docampo, LCI, Arrula, VA, Rotllan, NB, Maseda, AC, Cirauqui, BC, Escobar, Y, Sorrosal, JJL, Borgonon, MP, Rueda, A and Hernandez, JJC
Publicada:
1 ene 2018
Resumen:
Head and neck cancer (HNC) is defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence obtained since 2013 publication, Spanish Society of Medical Oncology (SEOM) presents an update of HNC diagnosis and treatment guideline. The eighth edition of TNM classification, published in January 2017, introduces important changes for p16-positive oropharyngeal tumours, for lip and oral cavity cancer and for N3 category. In addition, there are new data about induction chemotherapy and the role of immunotherapy in HNC.
Filiaciones:
Docampo, LCI:
Hosp Univ 12 Octubre, Madrid, Spain
Arrula, VA:
Hosp Basurto, Bilbao, Spain
Rotllan, NB:
Hosp Univ Vall dHebron, Barcelona, Spain
Maseda, AC:
Hosp Univ Lucus Augusti, Lugo, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Escobar, Y:
Hosp Gen Univ Gregorio Maranon, Madrid, Spain
Sorrosal, JJL:
Hosp Clin Univ Lozano Blesa, Zaragoza, Spain
Borgonon, MP:
Hosp Univ & Politecn La Fe, Valencia, Spain
Rueda, A:
Complejo Hosp Costa Sol, Malaga, Marbella, Spain
Hernandez, JJC:
Hosp Univ Salamanca, Salamanca, Spain
Green Published, hybrid
|